Compare · OPRX vs RELX
OPRX vs RELX
Side-by-side comparison of OptimizeRx Corporation (OPRX) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPRX and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX is the larger of the two at $62.96B, about 664.4x OPRX ($94.8M).
- Over the past year, OPRX is down 65.8% and RELX is down 34.9% - RELX leads by 30.9 points.
- OPRX has been more active in the news (6 items in the past 4 weeks vs 3 for RELX).
- RELX has more recent analyst coverage (12 ratings vs 11 for OPRX).
- Company
- OptimizeRx Corporation
- RELX PLC PLC
- Price
- $5.05-1.27%
- $34.52-1.78%
- Market cap
- $94.8M
- $62.96B
- 1M return
- -23.83%
- +1.07%
- 1Y return
- -65.81%
- -34.93%
- Industry
- Real Estate
- Real Estate
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 6
- 3
- Recent ratings
- 11
- 12
OptimizeRx Corporation
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest OPRX
- OptimizeRx Corporation filed SEC Form 8-K: Leadership Update
- SEC Form DEFA14A filed by OptimizeRx Corporation
- OptimizeRx to Participate in Upcoming Investor Conferences
- DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network
- Chief Commercial Officer Greco Theresa covered exercise/tax liability with 1,793 shares, decreasing direct ownership by 2% to 71,075 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Silvestro Stephen L covered exercise/tax liability with 5,219 shares, decreasing direct ownership by 3% to 185,288 units (SEC Form 4) to satisfy withholding tax
- SEC Form 10-Q filed by OptimizeRx Corporation
- OptimizeRx Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
- OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Latest RELX
- Goldman initiated coverage on RELX
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- Consumers Ready and Comfortable to Share their Medical Information Electronically for Easier Life Insurance Underwriting
- RELX downgraded by Morgan Stanley
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- WEPACK 2026 Concludes on a Record High, Reinforcing China's Role at the Heart of the Global Packaging Industry
- SEC Form 6-K filed by RELX PLC PLC
- Cytora and LexisNexis Risk Solutions announce strategic relationship to enhance risk selection and automation for U.S. commercial insurers